CONSTRUCTION OF RECOMBINANT HSCC-1 ADENOVIRUS VECTOR FOR ORAL CANCER GENE THERAPY |
Kim, Chang-Hyen
(Department of Oral and Maxillofacial Surgery, College of Medicine, The Catholic University of Korea)
Kim, Jin-Woo (Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea) Kim, Myung-Jin (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Pyo, Sung-Woon (Department of Oral and Maxillofacial Surgery, College of Medicine, The Catholic University of Korea) |
1 | Cusack JC, Jr, Tanabe KK : Cancer gene therapy. Surg Oncol Clin N Am 7 : 421, 1998 PUBMED |
2 | Xi S, Grandis JR : Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82 : 11, 2003 DOI ScienceOn |
3 | Anderson MJ, Stanbridge EJ : Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J 7 : 826, 1993 PUBMED |
4 | Cai DW, Mukhopadhyay T, Liu Y, et al : Stable expression of the wild-type p53 gene in humna lung cancer after retrovirus-mediated gene transfer. Hum Gene Ther 4 : 617, 1993 DOI ScienceOn |
5 | Wang J, Bucana CD, Roth JA, et al : Apoptosis induced in human osteosarcoma cells is one of the mechanims for the cytocidal effect of Ad5CMV-p53. Cancer Gene Ther 2 : 9, 1995 PUBMED |
6 | Rheinwald JG, Beckett MA : Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41 : 1657, 1981 PUBMED |
7 | He TC, Zhou S, DaCosta LT, et al : Simplified system for generating recombinant adenovirus. Proc Natl Acad Sci 95 : 2509, 1998 |
8 | Kim MS, Kwon HC, Hong SI, et al : Adenovirus-mediated gene transfer of wild-type p53 results in restoration of tumor suppressor gene function in glioma cell line. J Kor Cancer Assoc20: 1026, 1998 |
9 | Shillitoe EJ : Gene therapy for head and neck cancer. Oral Oncol 34 : 157, 1998 DOI PUBMED ScienceOn |
10 | Kim TE, Kim YW, Kim JW et al : Candidate tumor suppressor, HCCS-1, is downregulated in human cancers and induces apoptosis in cervical cancer. Int J Cancer 97 : 780, 2002 DOI ScienceOn |
11 | Kim TE, Ro DY, Kim YW, et al. Adenovirus-mediated thymidine kinase gene trasnfer with exposure of ganciclovir to uterine cervical cancer cell. Kor J Gynecol Oncol Colposcopy 14: 195, 2003 |
12 | Daqing L, Ling D, Paul F, et al : Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 5 : 4175, 1999 PUBMED |
13 | Clayman GL, Frank DK, Bruso PA, et al : Adenovirusmediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin Cancer Res 5 : 1715, 1999 PUBMED |
14 | Schrijvers D, Johnson J, Jiminez U, et al : Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study group. J Clin Oncol 16 : 1054, 1998 PUBMED |
15 | Graham FL, Smiley J : Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36 : 59, 1977 DOI ScienceOn |
16 | Zhang WW, Fang X, Mazur W, et al : High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1 : 5, 1994 PUBMED |
17 | Takenouchi, T, Munetaka E : Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci 56 : 479, 1995 DOI ScienceOn |
18 | Wolff JA, Trubetskoy VS : The Cambrian period of nonviral gene delivery (news). Nat Biotechnol 16 : 421, 1998 DOI ScienceOn |
19 | Cho SD, Hwang SJ, Park HR, et al. Development of gene therapy strategy using plasmid and adenovirus in cervical cancer treatment. J Kor Obstet Gynecol 42: 2019, 1999 |
20 | McGroy WJ, Bautista DS, Graham FL : A simple techniques for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163 : 614, 1988 DOI ScienceOn |
21 | Nemunaitis J, Ganly I, Khuri F, et al : Seletive replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer; a phase II trial. Cancer Res 60 : 6359, 2000 PUBMED |
22 | Fukuhara H, Hayashi Y, Yamamoto N, et al. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell line. Oral Oncol 39 : 601, 2003 DOI ScienceOn |
23 | Schwartz GJ, Mehta RH, Wenig BL, et al : Salvage management for recurrent squamous cell carcinoma of the oral cavity. Head Neck 22 : 34, 2000 DOI ScienceOn |
24 | Robbins PD, Tahara H, Ghivizzani SC : Viral vectors for gene therapy. Trends Biotechnol 16 : 35, 1998 DOI ScienceOn |
25 | Shillitoe EJ, Laypeyre JN, Adler-Storthz K : Gene therapy-it's potential in the management of oral cancer. Oral Oncol 3 : 957, 1996 |
26 | Liu TJ, Zhang WW, Taylor DL, et al : Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54 : 3662, 1994 PUBMED |
27 | Zhang WW : Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 6 : 113, 1999 DOI PUBMED ScienceOn |
28 | Hamada K, Sakaue M, Alemany R, et al : Adenovirus transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gyne Oncol 63 : 219, 1996 DOI ScienceOn |
29 | Chirmule N, Propert K, Magosin S, et al : Immune responses to adenovirus and adeno-associated virus in humans. Cancer Gene Ther 6 : 1574, 1999 |
30 | Sun LM, Leung SW, Su CY : The relapse patterns and outcome of postoperative recurrent tongue cancer. J Oral Maxillofac Surg 55 : 827, 1997 DOI ScienceOn |